William O. Osburn

3.8k total citations
43 papers, 2.9k citations indexed

About

William O. Osburn is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, William O. Osburn has authored 43 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 26 papers in Epidemiology and 13 papers in Molecular Biology. Recurrent topics in William O. Osburn's work include Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (21 papers) and Liver Disease Diagnosis and Treatment (12 papers). William O. Osburn is often cited by papers focused on Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (21 papers) and Liver Disease Diagnosis and Treatment (12 papers). William O. Osburn collaborates with scholars based in United States, Canada and Netherlands. William O. Osburn's co-authors include Thomas W. Kensler, Andrea L. Cox, Stuart C. Ray, Masayuki Yamamoto, David L. Thomas, Justin R. Bailey, Shyam Biswal, Anna E. Snider, Patrick M. Dolan and Kimberly A. Dowd and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Gastroenterology.

In The Last Decade

William O. Osburn

43 papers receiving 2.8k citations

Peers

William O. Osburn

HEPAT

EPIDE

RNMI

IMMUN

Sabine Mihm Germany

Maryse Guérin France

Willscott E. Naugler United States

Carmelo García‐Monzón Spain

Keisuke Hino Japan

Roland Buelow United States

Natalia A. Osna United States

P. L. M. Jansen Netherlands

Jie Zhao China

Ralph E. Kirsch South Africa

Sabine Mihm Germany

William O. Osburn

927 ×0.8

1.2k ×1.0

HEPAT

1.2k ×1.1

EPIDE

52 ×0.2

RNMI

993 ×3.3

IMMUN

Citations per year, relative to William O. Osburn William O. Osburn (= 1×) peers Sabine Mihm

Countries citing papers authored by William O. Osburn

Since Specialization

Citations

This map shows the geographic impact of William O. Osburn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William O. Osburn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William O. Osburn more than expected).

Fields of papers citing papers by William O. Osburn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William O. Osburn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William O. Osburn. The network helps show where William O. Osburn may publish in the future.

Co-authorship network of co-authors of William O. Osburn

This figure shows the co-authorship network connecting the top 25 collaborators of William O. Osburn. A scholar is included among the top collaborators of William O. Osburn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William O. Osburn. William O. Osburn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Osburn, William O., et al.. (2025). Increasing Access To Sexually Transmitted Infection Testing: The Promise of Point-of-Care and Over-the-Counter Tests. Current HIV/AIDS Reports. 22(1). 27–27. 1 indexed citations

Reventún, Paula, Maria Viskadourou, Alanna C. Morrison, et al.. (2023). CD36 regulates factor VIII secretion from liver endothelial cells. Blood Advances. 8(1). 143–149. 1 indexed citations

Arvanitis, Marios, William O. Osburn, Yaqiu Sang, et al.. (2023). High risk oral contraceptive hormones do not directly enhance endothelial cell procoagulant activity in vitro. PLoS ONE. 18(4). e0284333–e0284333. 4 indexed citations

Leucker, Thorsten M., William O. Osburn, Paula Reventún, et al.. (2021). Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19. JACC Basic to Translational Science. 6(12). 935–945. 20 indexed citations

Balagopal, Ashwin, Ruy M. Ribeiro, Hyon S. Hwang, et al.. (2020). Single hepatocytes show persistence and transcriptional inactivity of hepatitis B. JCI Insight. 5(19). 27 indexed citations

Massaccesi, Guido, Andrew I. Flyak, Madeleine C. Mankowski, et al.. (2019). Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance. Journal of Clinical Investigation. 129(11). 4786–4796. 36 indexed citations

Rodrigo, Chaturaka, Preston Leung, Andrew R. Lloyd, et al.. (2018). Genomic variability of within‐host hepatitis C variants in acute infection. Journal of Viral Hepatitis. 26(4). 476–484. 7 indexed citations

El–Diwany, Ramy, Madeleine C. Mankowski, Lisa N. Wasilewski, et al.. (2017). Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1. PLoS Pathogens. 13(2). e1006235–e1006235. 41 indexed citations

Tolan, Nicole V., Gary L. Horowitz, Camilla S. Graham, et al.. (2017). New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management. Clinical Chemistry. 63(12). 1799–1805. 2 indexed citations

10.

Patel, Eshan U., Andrea L. Cox, Shruti H. Mehta, et al.. (2016). Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection. The Journal of Infectious Diseases. 214(3). 344–352. 10 indexed citations

11.

Sacks‐Davis, Rachel, Jason Grebely, Gregory J. Dore, et al.. (2015). Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection—the InC³Study. The Journal of Infectious Diseases. 212(9). 1407–1419. 69 indexed citations

12.

Fiedler, Melanie, Dorothea Bankwitz, William O. Osburn, et al.. (2014). Hepatitis C Virus Hypervariable Region 1 Variants Presented on Hepatitis B Virus Capsid-Like Particles Induce Cross-Neutralizing Antibodies. PLoS ONE. 9(7). e102235–e102235. 7 indexed citations

13.

Osburn, William O., Anna E. Snider, Rachel Latanich, et al.. (2014). Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses. Hepatology. 59(6). 2140–2151. 206 indexed citations

14.

Vickerman, Peter, Jason Grebely, Gregory J. Dore, et al.. (2012). The More You Look, the More You Find: Effects of Hepatitis C Virus Testing Interval on Reinfection Incidence and Clearance and Implications for Future Vaccine Study Design. The Journal of Infectious Diseases. 205(9). 1342–1350. 55 indexed citations

15.

Grebely, Jason, Maria Prins, Margaret Hellard, et al.. (2012). Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. The Lancet Infectious Diseases. 12(5). 408–414. 173 indexed citations

16.

Chattergoon, Michael A., Jordana Levine, Rachel Latanich, et al.. (2011). High Plasma Interleukin-18 Levels Mark the Acute Phase of Hepatitis C Virus Infection. The Journal of Infectious Diseases. 204(11). 1730–1740. 45 indexed citations

17.

Osburn, William O., Melinda S. Yates, Sining Chen, et al.. (2008). Genetic or Pharmacologic Amplification of Nrf2 Signaling Inhibits Acute Inflammatory Liver Injury in Mice. Toxicological Sciences. 104(1). 218–227. 140 indexed citations

18.

Osburn, William O. & Thomas W. Kensler. (2007). Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults. Mutation Research/Reviews in Mutation Research. 659(1-2). 31–39. 441 indexed citations

19.

Osburn, William O., Baktiar Karim, Patrick M. Dolan, et al.. (2007). Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2‐deficient mice upon dextran sulfate treatment. International Journal of Cancer. 121(9). 1883–1891. 174 indexed citations

20.

Osburn, William O., Nobunao Wakabayashi, Vikas Misra, et al.. (2006). Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Archives of Biochemistry and Biophysics. 454(1). 7–15. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact